英文摘要 |
Acinetobacter baumannii is a major cause of healthcare-associated infections. It causes opportunistic infections with reduced susceptibility to carbapenems, tigecyclines, and polymyxins. In 2017, the World Health Organization (WHO) listed A. baumannii as a key pathogen and stated the urgent need to develop new antibiotics and alternative medicines accordingly. A. baumannii can survive on dry environmental surfaces for a long time and is highly resistant to cleaning agents and antibiotics. Capsular polysaccharides on their surface can retain water and help it survive in dry environments. The biofilm structure firmly attaches bacteria to surfaces in medical facilities. When environmental toxins and antibiotics enter this bacteria, the efflux pump activates and expels harmful substances. Within the past decade, many genomic studies have confirmed that these regulatory mechanisms play important roles in the survival of A. baumannii in healthcare settings. An in-depth understanding of the molecular mechanisms of this pathogen will aid in developing new infection control strategies to combat this intractable threat. Therefore, in this review article, we explore how A. baumannii survives in harsh environments. |